3 completed, 2 terminated, 1 not yet recruiting, 1 recruiting. 5 Phase 2, 3 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Terminated 2, Completed 1, Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 3 | Completed 2, Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow Metastatic Castrate Resistant Prostate Cancer: new trials by email Literature Review of Metastatic Castrate Resistant Prostate Cancer trials Research Report on Metastatic Castrate Resistant Prostate Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| LuX: Xaluritamig in Participants With Metastatic Castrate Resistant Prostate Cancer and Suboptimal Response to Lutetium 177 Vipivotide Tetraxetan Xaluritamig - Prostate Cancer, Metastatic Castrate Resistant Prostate Cancer | Phase 2 | Not yet recruiting | Thomas Jefferson University | 30 | 2026-10-01 | 2026-08-14 |
| Carboplatin or Olaparib for BRcA Deficient Prostate Cancer Carboplatin, Olaparib - Metastatic Castrate Resistant Prostate Cancer, BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2 | Phase 2 | Recruiting | VA Office of Research and Development | 100 | 2019-10-01 | 2026-09-17 |
| MGC018 With or Without MGA012 in Advanced Solid Tumors vobramitamab duocarmazine - Squamous Cell Carcinoma of Head and Neck, Triple Negative Breast Cancer | Phase 1 / Phase 2 | Terminated | MacroGenics | 143 | 2018-11-21 | 2025-07-31 |
| Fractionated Docetaxel and Radium 223 in Metastatic Castration-Resistant Prostate Cancer Docetaxel, Radium 223 - Metastatic Castrate Resistant Prostate Cancer | Phase 1 | Completed | Tufts Medical Center | 43 | 2018-01-30 | 2025-10-07 |
| Detection of ARv7 in the Plasma of Men With Advanced Metastatic Castrate Resistant Prostate Cancer (MCRP) Metastatic Castrate Resistant Prostate Cancer | Suspended | Exosome Diagnostics, Inc. | 30 | 2016-02-01 | 2022-10-06 | |
| Masitinib Plus Docetaxel in Metastatic Castration-resistant Prostate Cancer Masitinib, Docetaxel, Prednisone - Metastatic Castrate Resistant Prostate Cancer | Phase 3 | Completed | AB Science | 714 | 2014-09-01 | 2023-09-29 |
| A Proof of Concept Study of Maintenance Therapy With Tasquinimod in Patients With Metastatic Castrate-resistant Prostate Cancer Who Are Not Progressing After a First Line Docetaxel Based Chemotherapy Tasquinimod, Placebo - Metastatic Castrate Resistant Prostate Cancer | Phase 2 | Terminated | Ipsen | 144 | 2013-01-01 | 2019-11-22 |
| A Phase I/II Study of TRC105 in Metastatic Castrate Resistant Prostate Cancer (CRPC) TRC105 - Prostate Cancer, Metastatic Castrate Resistant Prostate Cancer | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 21 | 2010-02-23 | 2018-05-22 |
Prostatic Neoplasms (4) · Carcinoma, Non-Small-Cell Lung (1) · Fanconi Anemia, Complementation Group D1 (1) · Fanconi Anemia, Complementation Group N (1) · Hereditary Sensory and Autonomic Neuropathies (1) · Melanoma (1) · Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1) · Triple Negative Breast Neoplasms (1)
Neoplasms by Site (5) · Genital Diseases (4) · Genital Diseases, Male (4) · Genital Neoplasms, Male (4) · Male Urogenital Diseases (4) · Neoplasms (4) · Prostatic Diseases (4) · Urogenital Diseases (4) · Urogenital Neoplasms (4) · Breast Diseases (1) · Breast Neoplasms (1) · Bronchial Neoplasms (1) · Carcinoma (1) · Carcinoma, Bronchogenic (1) · Carcinoma, Squamous Cell (1)
Docetaxel (2) · Carboplatin (1) · Prednisone (1) · Radium-223 (1) · carotuximab (1) · masitinib (1) · olaparib (1) · radium Ra 223 dichloride (1) · tasquinimod (1)
AB Science (1) · Exosome Diagnostics, Inc. (1) · Ipsen (1) · MacroGenics (1) · National Cancer Institute (NCI) (1) · Thomas Jefferson University (1) · Tufts Medical Center (1) · VA Office of Research and Development (1)
United States (5) · France (2) · Italy (2) · Poland (2) · Spain (2) · Australia (1) · Belgium (1) · Canada (1) · Czechia (1) · Denmark (1) · Germany (1) · Hungary (1) · India (1) · Lithuania (1) · Malaysia (1)
Ashley Ward, M.D. (1) · Dominique Spaeth, MD (1) · Kevin K Zarrabi, MD, MS (1) · Maneesh Jain, MD (1) · Paul Mathew, MD (1) · Phoebe Tsao, MD MSc (1) · Robert B. Montgomery, MD (1) · Roger Tun (1) · Ryan Burri, MD (1) · William L Dahut, M.D. (1)